electroCore Enters Agreement with Spark Biomedical for Sparrow Ascent Distribution
electroCore, Inc. (NASDAQ: ECOR) is excited to announce its recent agreement with Spark Biomedical, Inc., a renowned name in the bioelectronic medicine field. This collaboration is centered around the distribution of the Sparrow Ascent™, an FDA-cleared device designed to help alleviate symptoms experienced during opioid withdrawal. The device, known for its non-invasive transcutaneous auricular neuromodulation capabilities, will be made available within select facilities of the Department of Veterans Affairs (VA).
Significance of the Partnership
The partnership marks a monumental step for both companies. Daniel Powell, the CEO of Spark Biomedical, expressed that their commitment to developing drug-free, wearable neurostimulation therapies aims to fill crucial gaps in addiction treatment. By teaming up with electroCore, they can extend the reach of Sparrow Ascent™, making it accessible to veterans who may benefit from its clinically validated approach to easing opioid withdrawal symptoms.
Dan Goldberger, CEO of electroCore, shared his enthusiasm about integrating the Sparrow Ascent treatment into their distribution network, particularly within the VA hospital system. He noted how vital it is to expand options for veterans facing opioid withdrawal and reaffirmed electroCore's commitment to providing innovative healthcare solutions.
The Sparrow Ascent™ Device
The Sparrow Ascent™ is a state-of-the-art device designed to offer a non-addictive, drug-free alternative for individuals grappling with opioid withdrawal. Its innovative technology focuses on providing therapeutic benefits through neurostimulation, potentially reducing the discomfort associated with withdrawal. This device is a welcome addition to existing treatment options and is expected to be particularly beneficial for veterans who are often at a higher risk of opioid dependence.
About Spark Biomedical, Inc.
Spark Biomedical stands out as a leader in the medical device field, dedicated to transforming the landscape of behavioral health, women’s health, and chronic pain management. The company specializes in developing innovative neurostimulation therapies that aim to enhance patient care. With a foundation rooted in neuroscience and engineering, Spark Biomedical is positioning itself as a pivotal player in the arena of bioelectronic medicine. They have garnered support from prominent federal entities and maintain collaborations with various private and academic institutions to further their mission of advancing healthcare technology.
About electroCore, Inc.
electroCore, Inc. is not just a bioelectronic medicine company but a firm believer in enhancing human wellness through the application of its innovative vagus nerve stimulation (nVNS) technology. The company’s primary focus lies in the commercialization of non-invasive medical devices that tackle specific health conditions while also promoting general well-being. Their flagship product, gammaCore™, has already made waves in the industry, and the addition of Sparrow Ascent is set to further expand their impact.
With a strong commercial sales organization already in place, electroCore is continuously exploring unique therapeutic solutions that cater to the diverse needs of its customers. The availability of Sparrow Ascent at VA facilities is a clear indication of their commitment to providing comprehensive support for veterans navigating recovery.
Innovative Solutions for Opioid Withdrawal
The introduction of Sparrow Ascent into the VA healthcare system under the aegis of electroCore represents a forward-thinking approach to addressing the opioid crisis. With an emphasis on non-pharmacological treatment options, this partnership stands to significantly improve the quality of care given to veterans. The hope is that through innovative devices like Sparrow Ascent, individuals struggling with opioid withdrawal can find effective relief without the risks associated with traditional medications.
Frequently Asked Questions
1. What is the purpose of the Sparrow Ascent™ device?
The Sparrow Ascent™ device is designed to provide non-invasive treatment for opioid withdrawal symptoms through neurostimulation.
2. Why is the partnership between electroCore and Spark Biomedical important?
This partnership facilitates the distribution of Sparrow Ascent™ to VA facilities, enhancing treatment access for veterans in need.
3. How does the Sparrow Ascent™ device work?
The device utilizes transcutaneous auricular neuromodulation to deliver therapeutic effects that can alleviate withdrawal symptoms.
4. Who can benefit from using Sparrow Ascent™?
Veterans facing opioid withdrawal symptoms are the primary beneficiaries of this device.
5. What is electroCore's mission in the healthcare sector?
electroCore aims to improve health and wellness through innovative, non-invasive medical devices, contributing to a broader range of treatment options for patients.
